Elevance Health, Inc.
ELV · NYSEElevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.
Financials and workspace tools are for paid members.
Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.